Beyeonics Vision Secures US Patent for Ophthalmic Surgical Visualization Technology

Beyeonics Vision announced the issuance of a US patent to protect its core technology for how surgeons visualize the eye during cataract and other ocular procedures. According to Beyeonics, the patent, titled “Systems and Methods for Imaging a Body Part During a Medical Procedure” safeguards a 3D imaging platform that uniquely integrates visible and infrared (IR) illumination. This combination is designed to deliver clarity, depth perception, and safety during surgery.

Beyeonics Vision’s newly patented system enables stereoscopic imaging that fuses IR and visible light, granting surgeons a sharper, deeper, and more information-rich view of ocular structures. This dual-spectrum approach is designed to enhance safety by improving visualization even in challenging surgical conditions, helping to prevent complications and improve outcomes.

“This patent is a cornerstone in our intellectual property portfolio,” said Burton Tripathi, CEO of Beyeonics Vision. “By combining IR and visible imaging in a stereoscopic format, we’re enabling safer, more precise, and more ergonomic cataract surgery, as was presented by multiple KOLs at the April 2025 ASCRS meeting in Los Angeles. This is not just an incremental improvement—it’s a revolutionary innovation that can redefine surgical visualization for decades to come.”

The patented technology is used on Beyeonics ONE, the company’s next-generation visualization system.